PhoenixBio Co., Ltd. (TYO:6190)

Japan flag Japan · Delayed Price · Currency is JPY
348.00
-3.00 (-0.85%)
Jul 16, 2026, 10:18 AM JST
Market Cap1.43B -7.9%
Revenue (ttm)1.57B +1.6%
Net Income125.00M
EPS30.75
Shares Out 4.07M
PE Ratio11.41
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume500
Open350.00
Previous Close351.00
Day's Range347.00 - 350.00
52-Week Range321.00 - 724.00
Beta0.36
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About PhoenixBio

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 55
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6190
Full Company Profile

Financial Performance

Financial Statements